Cenicriviroc is an experimental drug candidate for the treatment of HIV infection. It is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell. Synonyms: 8-[4-(2-Butoxyethoxy)phenyl]-1,2,3,4-tetrahydro-1-(2-methylpropyl)-N-[4-[(S)-[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl]phenyl]-1-benzazocine-5-carboxamide, (-)-8-[4-(2-Butoxyethoxy)phenyl]-1-isobutyl-N-[4-[[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl]phenyl]-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide, TB-652, Tobira CAS No: 497223-25-3 Mesylate Salt: 497223-28-6 Molecular Formula: C41H52N4O4S Molecular Weight: 696.94 Appearance: White to off-white solid Purity: 95% Solubility: DMF: 20mg/ml DMSO: 20mg/ml DMSO:PBS (pH 7.2) (1:1): 0.5mg/ml Ethanol: 5mg/ml Storage and Stability: May be stored at RT for short-term only. Long-term storage is recommended at 4C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
696.94
Purity:
95%
Form:
White to off-white solid
CAS Number:
[497223-25-3]
* VAT and and shipping costs not included. Errors and price changes excepted